Weill Cornell Medicine-Qatar (WCM-Q) has signed a research agreement with pioneering US biotechnology company Moderna, Inc. to develop a new cholesterol-controlling drug
Weill Cornell Medicine-Qatar (WCM-Q) has joined an elite group of research centres around the world that are certified to use a powerful new research tool for investigating the complex roles of proteins in human disease.
Weill Cornell Medicine-Qatar (WCM-Q) was invited to share its expertise on providing high-quality continuing medical education (CME) at the annual conference
Recent advances in anticoagulation therapies were explained in the latest instalment of Weill Cornell Medicine-Qatar’s (WCM-Q) series of Grand Rounds lectures.
Green-fingered students have received awards for their schools after growing bumper crops of fruit and vegetables for the Sahtak Awalan’s Project Greenhouse competition launched by Weill Cornell Medicine – Qatar (WCM-Q).
Researchers from leading institutions across Qatar convened at Weill Cornell Medicine-Qatar’s (WCM-Q) ninth annual research retreat to discuss the latest developments in biomedical science.
Weill Cornell Medicine-Qatar (WCM-Q) alumni working in Qatar spent a week learning leadership and management skills on a course organised by WCM-Q’s Division of Alumni Affairs.
State-of-the-art health monitoring technologies will be deployed to track and support the well being of workers on Qatar 2022 construction projects in the next phase of a programme ...
A symposium at Weill Cornell Medicine-Qatar (WCM-Q) explored the impact on health of the complex interactions between the nervous system, the gut and the microbiota – the micro-organisms living in the gut.